325 related articles for article (PubMed ID: 27863362)
1. Comparison of cardiovascular risk assessment tools and their guidelines in evaluation of 10-year CVD risk and preventive recommendations: A population based study.
Motamed N; Rabiee B; Perumal D; Poustchi H; Miresmail SJ; Farahani B; Maadi M; Saeedian FS; Ajdarkosh H; Khonsari MR; Hemasi GR; Zamani F
Int J Cardiol; 2017 Feb; 228():52-57. PubMed ID: 27863362
[TBL] [Abstract][Full Text] [Related]
2. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH
JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960
[TBL] [Abstract][Full Text] [Related]
3. Comparison of ACC/AHA and ESC Guideline Recommendations Following Trial Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: Results From the Population-Based Rotterdam Study.
Pavlovic J; Greenland P; Deckers JW; Brugts JJ; Kavousi M; Dhana K; Ikram MA; Hofman A; Stricker BH; Franco OH; Leening MJ
JAMA Cardiol; 2016 Sep; 1(6):708-13. PubMed ID: 27439175
[TBL] [Abstract][Full Text] [Related]
4. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
Pursnani A; Massaro JM; D'Agostino RB; O'Donnell CJ; Hoffmann U
JAMA; 2015 Jul; 314(2):134-41. PubMed ID: 26172893
[TBL] [Abstract][Full Text] [Related]
5. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
Mahabadi AA; Möhlenkamp S; Lehmann N; Kälsch H; Dykun I; Pundt N; Moebus S; Jöckel KH; Erbel R;
JACC Cardiovasc Imaging; 2017 Feb; 10(2):143-153. PubMed ID: 27665163
[TBL] [Abstract][Full Text] [Related]
6. Comparing Guidelines for Statin Treatment in Canada and the United States.
Hennessy DA; Bushnik T; Manuel DG; Anderson TJ
J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175357
[TBL] [Abstract][Full Text] [Related]
7. Comparison of four international cardiovascular disease prediction models and the prevalence of eligibility for lipid lowering therapy in HIV infected patients on antiretroviral therapy.
Begovac J; Dragović G; Višković K; Kušić J; Perović Mihanović M; Lukas D; Jevtović Đ
Croat Med J; 2015 Feb; 56(1):14-23. PubMed ID: 25727038
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Recommended Eligibility for Primary Prevention Statin Therapy Based on the US Preventive Services Task Force Recommendations vs the ACC/AHA Guidelines.
Pagidipati NJ; Navar AM; Mulder H; Sniderman AD; Peterson ED; Pencina MJ
JAMA; 2017 Apr; 317(15):1563-1567. PubMed ID: 28418481
[TBL] [Abstract][Full Text] [Related]
9. Comparison of different cardiovascular risk score calculators for cardiovascular risk prediction and guideline recommended statin uses.
Garg N; Muduli SK; Kapoor A; Tewari S; Kumar S; Khanna R; Goel PK
Indian Heart J; 2017; 69(4):458-463. PubMed ID: 28822511
[TBL] [Abstract][Full Text] [Related]
10. Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease based on available randomised clinical trial evidence: The Rotterdam Study.
Pavlović J; Greenland P; Deckers JW; Kavousi M; Hofman A; Ikram MA; Franco OH; Leening MJ
Eur J Prev Cardiol; 2018 Mar; 25(4):420-431. PubMed ID: 29171772
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 3 risk estimators to guide initiation of statin therapy for primary prevention of cardiovascular disease.
Ofori S; Dodiyi-Manuel S; Akpa MR
J Clin Lipidol; 2017; 11(6):1441-1447. PubMed ID: 29050979
[TBL] [Abstract][Full Text] [Related]
12. American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
Qureshi WT; Kaplan RC; Swett K; Burke G; Daviglus M; Jung M; Talavera GA; Chirinos DA; Reina SA; Davis S; Rodriguez CJ
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28495699
[TBL] [Abstract][Full Text] [Related]
13. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the European and US guidelines for lipid-lowering therapy in primary prevention of cardiovascular disease.
Delabays B; de La Harpe R; Vollenweider P; Fournier S; Müller O; Strambo D; Graham I; Visseren FLJ; Nanchen D; Marques-Vidal P; Vaucher J
Eur J Prev Cardiol; 2023 Nov; 30(17):1856-1864. PubMed ID: 37290056
[TBL] [Abstract][Full Text] [Related]
15. Applicability and potential clinical effects of 2013 cholesterol guidelines on major cardiovascular events.
Ko MJ; Kim YJ; Park CM; Lee SM; Lee WJ; Pencina MJ; Navar-Boggan AM; Park DW
Am Heart J; 2015 Sep; 170(3):598-605.e7. PubMed ID: 26385045
[TBL] [Abstract][Full Text] [Related]
16. Application of the European Society of Cardiology, Adult Treatment Panel III and American College of Cardiology/American Heart Association guidelines for cardiovascular risk management in a French cohort of rheumatoid arthritis.
Tournadre A; Tatar Z; Pereira B; Chevreau M; Gossec L; Gaudin P; Soubrier M; Dougados M
Int J Cardiol; 2015 Mar; 183():149-54. PubMed ID: 25666124
[TBL] [Abstract][Full Text] [Related]
17. Real-life evaluation of European and American high-risk strategies for primary prevention of cardiovascular disease in patients with first myocardial infarction.
Mortensen MB; Falk E
BMJ Open; 2014 Oct; 4(10):e005991. PubMed ID: 25326211
[TBL] [Abstract][Full Text] [Related]
18. Guideline-based statin/lipid-lowering therapy eligibility for primary prevention and accuracy of coronary artery calcium and clinical cardiovascular events: The Multi-Ethnic Study of Atherosclerosis (MESA).
Flueckiger P; Qureshi W; Michos ED; Blaha M; Burke G; Sandfort V; Herrington D; Yeboah J
Clin Cardiol; 2017 Mar; 40(3):163-169. PubMed ID: 27859433
[TBL] [Abstract][Full Text] [Related]
19. Comparison of risk assessment tools for cardiovascular diseases: results of an Iranian cohort study.
Motamed N; Ajdarkosh H; Perumal D; Ashrafi GH; Maadi M; Safarnezhad Tameshkel F; Farahani B; Rezaie N; Nikkhah M; Faraji AH; Miri SM; Roozafzai F; Khoonsari M; Karbalaie Niya MH; Zamani F
Public Health; 2021 Nov; 200():116-123. PubMed ID: 34717165
[TBL] [Abstract][Full Text] [Related]
20. Impact of statin guidelines on statin utilization and costs in an employer-based primary care clinic.
Gurgle HE; Schauerhamer MB; Rodriguez SA; McAdam-Marx C
Am J Manag Care; 2017 Dec; 23(12):e387-e393. PubMed ID: 29261246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]